Prospective Study to Assess Long‐Term Outcomes of Chelator‐Based Treatment With Trientine Dihydrochloride in Patients With Wilson Disease
This study demonstrated that treatment with TETA-2HCl was effective and well tolerated in hepatic and neurologic disease manifestations. Additionally, improvement in neurological symptoms was reported throughout the trial, suggesting that improvements may be reported for an extended period after initiation of therapy. <b>Trial Registration:</b> NCT02426905.
Authors
- Karl Heinz Weiss (ORCID: https://orcid.org/0000-0002-6336-9935)
- Isabelle Mohr (ORCID: https://orcid.org/0000-0001-7354-0241)
- Verena Aliane
- Carlot Kruse
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Krankenhaus Salem (DE)
Publication Details
- Journal
- JGH Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/jgh3.70114
- Primary Topic
- Trace Elements in Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00